Endotoxin-induced cytokine release from whole blood - similarities between monocyte dysfunction in septic disease and during postoperative acute phase response
Restricted accessOtherFirst published online February, 1997
Endotoxin-induced cytokine release from whole blood - similarities between monocyte dysfunction in septic disease and during postoperative acute phase response
Plasma levels of endotoxin, TNFα, interleukin-1β (IL-1β), and interleukin-6 (IL-6) as well as the endotoxin-induced release of these cytokines from whole blood were determined in 20 patients after elective aseptic surgery and eight patients suffering from septic disease. Blood samples were drawn before surgery as well as once daily over 7 days postoperatively. Endotoxin plasma levels increased on the day of the operation from 0.025 ± 0.005 EU/ml to 0.099 ± 0.022 EU/ml and remained elevated for 1 day. No changes were noted in the plasma levels of TNFα and IL-1. Levels of IL-6 increased to 198 ± 52 pg/ml on the day of the operation, while the release of TNFα and IL-6 markedly declined after whole blood was stimulated with endotoxin. The difference between basal and stimulated TNF values amounted to 505 ± 129 pg/ml preoperatively and 132 ± 41 pg/ml after the operation and 297 ± 28 pg/ml and 137 ± 43 pg/ml for IL-6. From the second day of the postoperative period onwards, the endotoxin-induced release of IL-6 was higher than the preoperative values. The results of whole blood stimulation in patients with sepsis were similar to those achieved directly after elective surgery. The cytokine release of TNFα, IL-1β, and IL-6 was reduced. We conclude that, during the early aseptic acute phase reaction, the changes in the functioning of monocytes resemble - qualitatively - those occurring during septic disease, and that this may be related to endotoxemia originating in the gastrointestinal tract.
Get full access to this article
View all access options for this article.
References
1.
Murata A., Ogawa M., Yasuda T. et al. Serum interleukin 6, C-reactive protein and pancreatic secretory trypsin inhibitor (PSTI) as acute phase reactants after major thoraco-abdominal surgery. Immunol Invest1990; 19: 271-278.
2.
Andus T., Geiger T., Hirano T., Kishimoto T., Heinrich P.C.Action of recombinant human interleukin 6, interleukin 1β and tumor necrosis factor α on the mRNA induction of acute-phase proteins . Eur J Immunol1988; 18: 739-746.
3.
Castell J.V. , Gomez-Lechon M.J., David M. et al. Interleukin-6 is the major regulator of the acute-phase protein synthesis in adult human hepatocytes. FEBS Lett1989; 242: 237-239.
4.
Cruickshank A.M., Fraser W.D., Bums H.J.G., van Damme J., Shenkin A.Response of serum interleukin-6 in patients undergoing elective surgery of varying severity . Clin Sci1990; 79: 161-165.
5.
Wortel C.H., van Deventer S.J., Aarden L.A. et al. Interleukin-6 mediates host defense responses induced by abdominal surgery. Surgery1993; 114: 564-570.
6.
Kragsbjerg P. , Holmberg H., Vikerfors T.Serum concentrations of interleukin-6, tumour necrosis factor-α, and C-reactive protein in patients undergoing major operations. Eur J Surg1995; 161: 17-22.
7.
Berger D., Bölke E., Hügel H., Seidelmann M., Hannekum A., Beger H.G.New aspects concerning the regulation of the postoperative acute phase reaction during cardiac surgery. Clin Chim Acta1995 ; 239: 121-130.
8.
Crozier T.A. , Muller J.E., Quittkat D., Sydow M., Wuttke W., Kettler D.Effect of anaesthesia on the cytokine responses to abdominal surgery. Br J Anaesth1994; 72: 280-285.
9.
Ohzato H., Yoshizaki K., Nishimoto N. et al. Interleukin-6 as a new indicator of inflammatory status: detection of serum levels of interleukin-6 and C-reactive protein after surgery. Surgery1992;111:201-209.
10.
Brandtzaeg P., Mollnes T.E., Kierulf P.Complement activation and endotoxin levels in systemic meningococcal disease. J Infect Dis1989; 160: 58-65.
11.
van Deventer S.J., Buller H.R., ten Cate J.W., Sturk A., Pauw W. Endotoxaemia: an early predictor of septicaemia in febrile patients. Lancet.1988; 1:605-609.
12.
Danner R.L. , Elin R.J., Hosseini J.M., Wesley R.A., Reilly J.M., Parillo J.E.Endotoxemia in human septic shock. Chest1991; 99: 169-175.
13.
Michie H.R. , Manogue K.R., Spriggs D.R. et al. Detection of circulating tumor necrosis factor after endotoxin administration. N Engl J Med1988; 318: 1481-1486.
14.
van Deventer S.J., Bueller H.R., ten Cate J.W., Aarden L.A., Hack C.E., Sturk A.Experimental endotoxemia in humans: analysis of cytokine release and coagulation, fibrinolytic, and complement pathways . Blood1990; 76: 2520-2526.
15.
Busch J., Hammer M., Brunkhorst R., Wagener P.Endotoxinbestimmung bei entzuendlich-rheumatischen Erkrankungen - Der Einfluss nichtsteroidaler Antiphlogistika auf die Darmpermeabilitaet. (Determination of endotoxin in inflammatory rheumatic diseases - the effect of nonsteroidal anti-inflammatory agents on intestinal permeability.)Z Rheumatol1988; 47: 156-160.
16.
Bigatello L.M. , Broitman S.A., Fattori L. et al. Endotoxemia, encephalopathy, and mortality in cirrhotic patients. Am J Gastroenterol1987; 82: 11-15.
17.
Gardiner K.R. , Halliday M.L., Barclay G.R. et al. Significance of systemic endotoxaemia in inflammatory bowel disease. Gut1995; 36: 897-901.
18.
Rush Jr B.F. , Sori A.J., Murphy T.F., Smith S., Flanagan Jr J.J., Machiedo G.W.Endotoxemia and bacteremia during hemorrhagic shock. The link between trauma and sepsis ? Ann Surg1988; 207: 549-554.
19.
Hiki N., Berger D., Buttenschoen K. et al. Endotoxemia and specific antibody behaviour against different endotoxins following multiple injury. J Trauma1995; 38: 794-801.
20.
Andersen L.W. , Landow L., Baek L., Jansen E., Baker S.Association between gastric intramucosal pH and splanchnic endotoxin, antibody to endotoxin, and tumor necrosis factor-alpha concentrations in patients undergoing cardiopulmonary bypass. Crit Care Med1993; 21: 210-217.
21.
Berger D., Schmidt U.M., Ott S., Seidelmann M., Martin R., Beger H.G.Incidence and pathophysiological relevance of postoperative endotoxemia . FEMS Immunol Med Microbiol1995; 11: 285-290.
22.
Roumen R.M. , Frieling J.T., van Tits H.W., van der Vliet J.A., Goris R.J.Endotoxemia after major vascular operations. J Vasc Surg1993 ; 18: 853-852
23.
Lin R.Y., Astiz M.E., Saxon J.C., Saha D.C., Rackow E.C.Relationships between plasma cytokine concentrations and leukocyte functional antigen expression in patients with sepsis. Crit Care Med1994; 22: 1595-1602.
24.
Volk H.D., Thieme M., Heym S. et al. Alterations in function and phenotype of monocytes from patients with septic disease- predictive value and new therapeutic strategies. Behring Inst Mitt1991; 90: 208-215.
25.
Athlin L., Holmberg S.B., Hafstrom L.Macrophage function and surgery. A clinical review with special reference to phagocytosis. Eur J Surg1991; 157: 163-170.
26.
Perttila J. , Salo M., Pirttikangas C.O., Jalonen J., Vainio O.Effects of cardiopulmonary bypass on lymphocytes and their subset counts with or without use of autotransfusion devices. J Cardiothorac Vasc Anesth1994; 8: 532-535.
27.
DeForge L.E. , Remick D.G.Kinetics of TNF, IL-6, and IL-8 gene expression in LPS-stimulated human whole blood. Biochem Biophys Res Commun1991; 174: 18-24.
28.
Members of the American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference Committee.Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med1992; 20: 864-874.
29.
Berger D., Beger H.G.Neue Aspekte zur Pathogenese und Behandlung der Sepsis und des septischen Schocks. Chirurg1991; 62: 783-788.
30.
Dobke M.K., Simoni J., Ninnemann J.L., Garrett J., Harnar T.J.Endotoxemia after burn injury: effect of early excision on circulating endotoxin levels. J Burn Care Rehabil1989 ; 10: 107-111.
31.
Martinez-Pellus A.E., Merino P., Bru M. et al. Can selective digestive decontamination avoid the endotoxemia and cytokine activation promoted by cardiopulmonary bypass? Crit Care Med1993 ; 21: 1684-1691.
32.
Liu X.S., Yang Z.C., Luo Z.H., Li A.Clinical significance of the change of blood monocytic interleukin-1 production in vitro in severely burned patients. Burns1994; 20: 302-306.
33.
Simpson S.Q. , Modi H.N., Balk R.A., Bone R.C., Casey L.C.Reduced alveolar macrophage production of tumor necrosis factor during sepsis in mice and men. Crit Care Med1991; 19: 1060-1066.
34.
Astiz M.E., Rackow E.C., Still J.G. et al. Pretreatment of normal humans with monophosphoryl lipid A induces tolerance to endotoxin: a prospective, double-blind, randomized, controlled trial. Crit Care Med1995; 23: 9-17.
35.
Todd N.J., Whicher J.T., Westacott C., Gilbert A.The acute phase protein response in mice does not show tolerance to recurrent sterile inflammation. Clin Chim Acta1990; 189: 47-54.
36.
McCall C.E. , Grosso Wilmoth L. M., LaRue K., Guzman R.N., Cousart S.L.Tolerance to endotoxin-induced expression of the interleukin-1 beta gene in blood neutrophils of humans with the sepsis syndrome. J Clin Invest1993; 91: 853-861.
Li M.H. , Seatter S.C., Manthei R., Bubrick M., West M.A.Macrophage endotoxin tolerance: effect of TNF or endotoxin pretreatment. J Surg Res1994; 57: 85-92.
39.
Seatter S.C. , Bennet T., Li M.H., Bubrick M.P., West M.A.Macrophage endotoxin tolerance. Tumor necrosis factor and interleukin-1 regulation by lipopolysaccharide pretreatment. Arch Surg1994; 129: 1263-1269.
40.
Wright S.D. , Ramos R.A., Tobias P.S., Ulevitch R.J., Mathison J.C.CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science1990 ; 249: 1431-1433.
41.
Birkenmaier C., Hong Y.S., Horn J.K.Modulation of the endotoxin receptor (CD 14) in septic patients. J Trauma1992; 32: 473-478.
42.
Mengozzi M. , Fantuzzi G., Sironi M. et al. Early down-regulation of TNF production by LPS tolerance in human monocytes: comparison with IL-1 beta, IL-6, and IL-8. Lymphokine Cytokine Res1993; 12: 231-236.
43.
Ziegler Heitbrock H.W., Wedel A., Schraut W. et al. Tolerance to lipopolysaccharide involves mobilization of nuclear factor kappa B with predominance of p50 homodimers . J Biol Chem1994; 269: 17001-17004.
44.
Labeta M.O. , Durieux J.J., Spagnoli G., Fernandez N., Wijdenes J., Herrmann R.CD 14 and tolerance to lipopolysaccharide: biochemical and functional analysis. Immunology1993; 80: 415-423.
45.
Mathison J. , Wolfson E., Steinemann S., Tobias P., Ulevitch R.Lipopolysaccharide (LPS) recognition in macrophages. Participation of LPS-binding protein and CD 14 in LPS-induced adaptation in rabbit peritoneal exudate macrophages. J Clin Invest1993; 92: 2053-2059.
46.
Schade F.U. , Franke C., Schlegel J., Rietschel E.T.Formation of a TNF synthesis inhibitor in endotoxin tolerance. Prog Clin Biol Res1995 ; 392: 513-521.
47.
Seatter S.C. , Bennet T., Li M.H., Bubrick M.P., West M.A.Macrophage endotoxin tolerance. Tumor necrosis factor and interleukin-1 regulation by lipopolysaccharide pretreatment. Arch Surg1994; 129: 1263-1269.
